Anticoagulants bleeding risk with

Doses and contraindications to glycoprotein Ilb/IIIa receptor blockers are described in Table 5-2. Major bleeding and rates of transfusion are increased with administration of a glycoprotein Ilb/IIIa receptor inhibitor in combination with aspirin and an anticoagulant,30 but there is no increased risk of intracranial hemorrhage in the absence of concomitant fibrinolytic treatment. The risk of thrombocytopenia with tirofiban and eptifibatide appears lower than that with abciximab. Bleeding risks appear similar between agents. 

Heparin is associated with an increased risk of bleeding either due to over anticoagulation or the occurrence of heparin inducted thrombocytopenia. The risk of major bleeding associated with heparin is reported to be 0% to 7% (7,8). The long-term administration of UFH may also be associated with osteopenia, Other reported adverse effects include skin lesions, priaprism, and elevated liver enzymes,... 

Anticoagulant (warfarin) and antiplatelet agents (ticlopidine, clopidogrel) reduced platelet adhesiveness and G1 tract damage by NSAIDs increase risk of alimentary bleeding (notably with azapropazone). Phenylbutazone, and probably azapropazone, inhibit the metabolism of warfarin, increasing its effect. 

Warfarin + mefenamic acid Enhanced anticoagulant blood levels with risk of haemorrhage and enhanced risk of Gl bleeding Displacement from protein Concurrent administration is best avoided. If necessary, coagulation limes should be monitored... 

Theoretical risk of increased bleeding when combined with anticoagulants Theoretical risk of increased bleeding when combined with anticoagulants Theoretical risk of increased bleeding when combined with anticoagulants... 

The prothrombin time (PT), as proposed by Quick, is the most commonly performed coagulation function test. It is used to monitor oral anticoagulant therapy and also as a preoperative screening test to warn of possible bleeding risk in patients with a personal or family history of bleeding (Table 36-2). Measured clotting times are extremely dependent on the animal and tissue source and the quality of the thromboplastin used. Variability can be expected because of the assay s dependence on the number of tissue factor molecules and the quantity of... 

Increased risk of bleeding with anticoagulants. Increased risk of Gl ulceration with alcohol, corticosteroids, phenylbutazone, oxyphenbutazone. Decreases uricosurea effects of probenecid and sulfinpyrazone and diuretic effects of spironolactone. Decreases absorption of tetracycline. Increases plasma levels of methotrexate. 

Isolated cases of increased prothrombin times and/or bleeding have been seen in patients given amoxicillin (with or without cla-vulanic acid) intravenous benzylpenicillin, phenedcillin or ta-lampicillin. An increased risk of over-anticoagulation was seen with amoxicillin with or without clavulanic acid in cohort studies, but not flucloxacillin. There is also some evidence that phe-noxymethylpenicillin (penicillin V) does not interact. 

---